Results 21 to 30 of about 3,929 (111)

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2

Therapeutic Advances in Musculoskeletal Disease, 2023
Background: Psoriatic arthritis (PsA) is a chronic inflammatory condition predominantly affecting the peripheral joints. However, some patients with PsA can experience axial involvement which is manifested with back pain and associated with increased ...
Atul Deodhar, Dafna Gladman, Rebecca Bolce, David Sandoval, So Young Park, Soyi Liu Leage, Peter Nash, Denis Poddubnyy   +7 more
doaj   +1 more source

The course of ankylosing spondylitis during pregnancy: intermediate data of a prospective follow-up

Современная ревматология, 2019
The onset of ankylosing spondylitis (AS) more frequently occurs at the end of the third decade of life, which corresponds to the time of marriage and the birth of the first child and determines the relevance of a study of the interaction of AS and ...
O. A. Krichevskaya, Z. M. Gandaloeva, A. B. Demina, T. V. Dubinina   +3 more
doaj   +1 more source

Avaliação do desempenho do BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) numa coorte brasileira de 1.492 pacientes com espondiloartrites: dados do Registro Brasileiro de Espondiloartrites (RBE)

Revista Brasileira de Reumatologia, 2015
Objetivo Avaliar os resultados da aplicação do Índice de Atividade de Doença da Espondilite Anquilosante de Bath (BASDAI) numa série de pacientes brasileiros com EpA e estabelecer suas correlações com as variáveis específicas do grupo.
Izaias Pereira da Costa, Adriana B. Bortoluzzo, Célio R. Gonçalves, José Antonio Braga da Silva, Antonio Carlos Ximenes, Manoel B. Bértolo, Sandra L.E. Ribeiro, Mauro Keiserman, Rita Menin, Thelma L. Skare, Sueli Carneiro, Valderílio F. Azevedo, Walber P. Vieira, Elisa N. Albuquerque, Washington A. Bianchi, Rubens Bonfiglioli, Cristiano Campanholo, Hellen M.S. Carvalho, Angela L.B. Pinto Duarte, Charles L. Kohem, Nocy H. Leite, Sonia A.L. Lima, Eduardo S. Meirelles, Ivânio A. Pereira, Marcelo M. Pinheiro, Elizandra Polito, Gustavo G. Resende, Francisco Airton C. Rocha, Mittermayer B. Santiago, Maria de Fátima L.C. Sauma, Valéria Valim, Percival D. Sampaio-Barros   +31 more
doaj   +1 more source

OPTIMIZING EXISTING TOOLS FOR REACHING AN ADEQUATE DISEASE CONTROL IN PATIENTS WITH SPONDYLOARTHRITIS [PDF]

Romanian Journal of Rheumatology, 2016
Background/Objective. Disease activity in spondyloarthritis (SpA) is evaluated through conventional scores such as BASDAI or ASDAS. The aim of this study was to determine disease activity in SpA patients under biological therapy with further assessment ...
Claudia Deaconu, Daniela Opris, Diana Mazilu, Laura Groseanu, Andreea Borangiu, Saulescu Ioana, Alexandra Peltea, Magdalena Negru, Cosmin Constantinescu, Violeta Vlad, Violeta Bojinca, Andra Balanescu, Denisa Predeteanu, Ruxandra Ionescu   +13 more
doaj   +1 more source

Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis

Frontiers in Medicine, 2022
BackgroundTo evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing spondylitis (AS).MethodsAncillary analysis of the MIDAS study, an observational, non ...
Cristina Fernández-Carballido, Vega Jovaní, Emma Beltrán Catalán, Manuel José Moreno-Ramos, Jesús Sanz Sanz, Adela Gallego, M. Luz García Vivar, José Manuel Rodríguez-Heredia, Cristina Sanabra, Carlos Sastré   +9 more
doaj   +1 more source

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

RMD Open, 2020
Objectives To compare definitions of high disease activity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in selecting patients for treatment with biologic disease-modifying ...
Sofia Ramiro, Elsa Vieira-Sousa, Alexandre Sepriano, Helena Santos, Jose Marona, Santiago Rodrigues-Manica, Fernando Pimentel-Santos, Ana Filipa Mourão, Nélia Gouveia, Jaime Cunha Branco, Filipe Vinagre, João Tavares-Costa, João Rovisco, Miguel Bernardes, Nathalie Madeira, Rita Cruz-Machado, Raquel Roque, Joana Leite Silva, Mary Lucy Marques, Raquel Miriam Ferreira   +19 more
doaj   +1 more source

Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity

Rheumatology
Axial spondyloarthritis (axSpA) is an inflammatory joint disease, in which the dominant symptom is inflammatory back pain. It affects approximately 1% of the population, with a higher incidence in males.
Katarzyna Małgorzata Wiąk-Walerowicz, Ewa Wielosz   +1 more
doaj   +1 more source

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study

Rheumatology and Therapy, 2023
Introduction We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in adults with active ankylosing spondylitis (AS) in the GO-ALIVE trial.
Atul Deodhar, Natalie J. Shiff, Cinty Gong, Eric K. H. Chan, Elizabeth C. Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D. Reveille   +9 more
doaj   +1 more source

Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year [PDF]

Терапевтический архив, 2017
Aim. To assess changes in the concentration of interleukin-17A (IL-17A) in patients with ankylosing spondylitis (AS) treated with tumor necrosis factor-α (TNFα) inhibitors during a year. Subjects and methods. Examinations were made in 30 patients (22 (73.
I Z Gaydukova, A P Rebrov, A V Aparkina, E V Khondkaryan   +3 more
doaj   +1 more source

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

RMD Open, 2020
Objectives In axial spondyloarthritis (axSpA), higher body mass index (BMI) is associated with worse outcomes including response to biologics. Further clarity is needed on whether BMI is associated with disease activity overall, independent of treatment ...
Lianne S Gensler, Namrata Singh, Jean W Liew, Irvin J Huang, Diana N Louden   +4 more
doaj   +1 more source